Key facts
| Price (PPV) | 33.60 MAD |
|---|---|
| Dispensing status | Schedule C — prescription only |
| Composition (DCI) | acide tiaprofénique |
| Class | Antiinflammatory and antirheumatic products |
| ATC code | M01AE11 |
| Manufacturer | PHARMED |
| Presentation | Boite de 20 |
| Nature | Médicament |
| Hospital price | 21 MAD |
| Data collected on | 9/8/2026 |
Indications
Elles sont limitées, chez l’adulte et l’enfant à partir de 15 kg (soit environ à partir de 4 ans), au : - traitement symptomatique au long cours : * des rhumatismes inflammatoires chroniques, notamment polyarthrite rhumatoïde, * de certaines arthroses douloureuses et invalidantes ; - traitement symptomatique de courte durée : * des poussées aiguës d’arthrose, de lombalgies, * des affections aiguës post-traumatiques bénignes de l’appareil locomoteur ; - dysménorrhée après recherche étiologique ; - traitement symptomatique de la douleur au cours des manifestations inflammatoires dans les domaines ORL et stomatologiques. Dans cette indication, les risques encourus, en particulier l’extension d’un processus septique concomitant sont ceux des AINS. Ils doivent être évalués par rapport au bénéfice antalgique attendu.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Atiaf 200 mg (PHARMED) contains the same active substance as Atiaf 200 mg (Acide tiaprofénique) at the same strength, but in a different pack: Boite de 10 at 18.90 MAD, i.e. 1.89 MAD per unit against 1.68 MAD for Atiaf 200 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Molgam 200 mg | PHARMA5 | Boîte de 20 | 37.40 MAD | 1.87 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Atiaf 200 mg | PHARMED | Boite de 10 | 18.90 MAD | 1.89 / unit |
| Molgam 200 mg | PHARMA5 | Boîte de 10 | 20.60 MAD | 2.06 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Atiaf 200 mg
Atiaf 200 mg belongs to the antiinflammatory and antirheumatic products therapeutic class. In Morocco, this drug is marketed by PHARMED and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Atiaf 200 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Atiaf 200 mg
Answers to common questions from Moroccan patients about this drug.